Skip to main content
. 2016 Nov 24;21:10.3402/meo.v21.33616. doi: 10.3402/meo.v21.33616

Table 2.

STORM TeleECHO provider self-efficacy, benefits, and practice measures

Provider self-efficacy: rate your ability to do each of the following
 Provide primary care for pediatric patients with SCD
 Provide primary care for adult patients with SCD
 Manage acute pain in pediatric patients with SCD
 Manage acute pain in adult patients with SCD
 Manage chronic pain in pediatric patients with SCD
 Manage chronic pain in adult patients with SCD
 Identify suitable candidates for disease modifying therapies, such as hydroxyurea
 Prescribe disease modifying therapies, such as hydroxyurea
 Serve as a provider for SCD patients
Provider benefits: provide your assessment for each of the following
 Through the STORM TeleECHO telehealth clinics, I am learning best-practice care for SCD
 I learn with guidance from STORM TeleECHO specialists in SCD management, whose knowledge and skills I respect
 I am developing my clinical expertise through participation in STORM TeleECHO
 My participation in STORM TeleECHO benefits patients under my care
 The patients under my care receive best-practice care for SCD
 I apply what I have learned about best practices through STORM TeleECHO to all of my patients with SCD
Provider practices: describe the current treatment patterns for your patients
 Of the patients you see with SCD, what percentage is eligible for hydroxyurea?
 Of the patients eligible, what percentage has been prescribed hydroxyurea?
 What percentage of patients is up to date with pneumococcal vaccinations, as documented in the medical record?
 What percentage of patients is on chronic transfusions (>4–6 transfusions in the past 12 months)?